Diabetes mellitus and heart failure

Congestive Heart Failure

Volumn 9, Issue 3, 2003, Pages 133-141

  Jagasia, Dinesh ^a   McNulty, Patrick H ^b  

^a UNIVERSITY OF IOWA   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 4; MUSCLE PROTEIN; SLC2A4 PROTEIN, HUMAN;

CARDIOVASCULAR RISK; CELL ULTRASTRUCTURE; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENERGY METABOLISM; FATTY ACID BLOOD LEVEL; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT SYSTEM; HEART FAILURE; HEART MUSCLE CELL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; ANIMAL; BLOOD; CONGESTIVE HEART FAILURE; DIABETIC ANGIOPATHY; HEART MUSCLE; METABOLISM; PHOSPHORYLATION;

ANIMALS; BLOOD GLUCOSE; DIABETIC ANGIOPATHIES; ENERGY METABOLISM; FATTY ACIDS, NONESTERIFIED; GLUCOSE TRANSPORTER TYPE 4; HEART FAILURE, CONGESTIVE; HUMANS; INSULIN; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MYOCARDIUM; PHOSPHORYLATION;

EID: 0041819882     PISSN: 10797998     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-5299.2002.00901.x     Document Type: Review

References (53)

1. King H, Aubert R, Herman W. Global burden of diabetes, 1995-2025: prevalence, numerical estimates and projections. Diabetes Care. 1998;21:1414-1431.
2. Kannel WB, McGee DL. Diabetes and glucose intolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care. 1979;2:120-126.
3. Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434-444.
4. Zimmet PZ. The changing face of macrovascular disease in non-insulin-dependent mellitus: an epidemic in progress. Lancet. 1997;350(suppl 1):SI1-SI4.
5. Nathan DM, Meigs J, Singer DE. The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is...or is it? Lancet. 1997;350(suppl 1):SI4-SI9.
6. Woodfield SL, Lundergan CF, Reiner JS, et al. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-1 experience. J Am Coll Cardiol 1996;28:1661-1669.
7. Paty BW. Managing myocardial infarction in the diabetic patient. Endocrinol Metab Clin North Am. 2000;29:831-842.
8. Solang L, Malmberg K, Ryden L. Diabetes mellitus and congestive heart failure. Further knowledge needed. Eur Heart J. 1999;20:789-795.
9. Garcia MJ, McNamara PM, Gorden T, et al. Morbidity and mortality in diabetics in the Framingham population. Sixteen-year follow-up study. Diabetes. 1974;23:105-111.
10. Devereux RB, Roman MJ, Paranicas M, et al. Impact of diabetes on cardiac structure and function: the Strong Heart study. Circulation. 2000;101:2271-2276.
11. Ahmed SS, Jaferi GA, Narang RM, et al. Preclinical abnormality of left ventricular function in diabetes mellitus. Am Heart J. 1975;89:153-158.
12. Borow KM, Jaspan JB, Williams KA, et al. Myocardial mechanics in young adult patients with diabetes mellitus: effects of altered load, inotropic state and dynamic exercise. J Am Coll Cardiol. 1990;15:1508-1517.
13. Mizushige K, Yoa L, Noma T, et al. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant pre-diabetic stage of a type II diabetic rat model. Circulation. 2000;101:899-907.
14. Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type-2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-234.
15. Miettinen H, Lehto S, Salomaa V, et al. Impact of diabetes on mortality after first myocardial infarction. The FINMONICA Myocardial Infarction Registry Study Group. Diabetes Care. 1998;21:69-75.
16. Jaffee AS, Spadaro JJ, Schectman K, et al. Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J. 1984;108:31-35.
17. O'Connor CM, Hathaway WR, Bates ER, et al. Clinical characteristics and long-term outcome in patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model. Am Heart J. 1997;133:663-673.
18. Taegtmeyer H. Energy metabolism of the heart: from basic concepts to clinical applications. Curr Probl Cardiol. 1994;19:62-101.
19. Weiss RG, Chacko V, Glickson J, et al. Comparative 13C and 31P NMR assessment of altered metabolism during graded reductions in coronary flow in intact rat hearts. Proc Natl Acad Sci U S A. 1989;86:6426-6430.
20. McNulty PH, Sinusas A, Shi QX, et al. Glucose metabolism distal to a critical coronary stenosis in a canine model of low-flow myocardial ischemia. J Clin Invest. 1996;98:1106-1114.
21. Janier MF, Vanoverschelde J-L, Bergmann SR, et al. Ischemic preconditioning stimulates anaerobic glycolysis in the isolated rabbit heart. Am J Physiol. 1994;267:H1353-H1360.
22. Xu KY, Zweier JL, Becker LC, et al. Functional coupling between glycolysis and sarcoplasmic reticulum Ca2+ transport. Circ Res. 1995;77:88-97.
23. Weiss J, Hiltbrand H. Functional compartmentation of glycolytic versus oxidative metabolism in isolated rabbit heart. J Clin Invest. 1985;75:436-447.
24. Jeremy RW, Ambrosio G, Pike MM, et al. The functional recovery of postischemic myocardium requires glycolysis during early reperfusion. J Mol Cell Cardiol. 1993;25:261-276.
25. Eberli FR, Weinberg EO, Grice WN, et al. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circ Res. 1991;68:466-481.
26. Apstein CS, Gravino FN, Haudenschild CC. Determinants of a protective effect of glucose and insulin on the ischemic myocardium. Effects on contractile function, diastolic compliance, metabolism and ultrastructure during ischemia and reperfusion. Circ Res. 1983;52(5):515-526.
27. Doenst T, Richwine RT, Bray MS, et al. Insulin improves functional and metabolic recovery of reperfused rat heart. Ann Thorac Surg. 1999;67:1682-1688.
28. Cavallini L, Valente M, Rigobello MP. The protective action of pyruvate on recovery of ischemic rat heart, comparison with other oxidizable substrates. J Mol Cell Cardiol. 1990;22:143-154.
29. McVeigh JJ, Lopaschuk GD. Dichloroacetate stimulation of glucose oxidation improves recovery of perfused working rat heart. Am J Physiol. 1990;259:H1079-H1085.
30. McCormack JG, Barr RL, Wolff AA, et al. Ranolazine stimulates glucose oxidation in normoxic, ischemic and reperfused ischemic rat hearts. Circulation. 1996;93:135-142.
31. Sun D, Nguyen N, Degrado TR, et al. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes. Circulation. 1994;89:793-798.
32. Tian R, Abel ED. Responses of GLUT4-deficient hearts to ischemia underscores the importance of glycolysis. Circulation. 2001;103:2961-2966.
33. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest. 2000;106:171-176.
34. Cline G, Petersen KF, Krssak M, et al. Inpaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type-2 diabetes. N Engl J Med. 1999;341:240-246.
35. Rothman DL, Magnusson I, Cline G, et al. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 1995;92:983-987.
36. Voipio-Pulkki L-M, Nuutila P, Knuuti MJ, et al. Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography. J Nucl Med. 1993;34:2064-2067.
37. Paternostro G, Camici PG, Lammerstma AA, et al. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease: a study with position emission tomography. J Clin Invest. 1996;98:2094-2099.
38. Jagasia D, Whiting JM, Concato J, et al. Effect of non-insulin-dependent diabetes mellitus on myocardial insulin responsiveness in patients with ischemic heart disease. Circulation. 2001;103:1734-1739.
39. Swan J, Anker S, Walton C, et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol. 1997;30:527-532.
40. Amato L, Paolisso G, Cacciatore F, et al. Congestive heart failure predicts the development of non-insulin-dependent mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group. Diabetes Metab. 1997;23:213-218.
41. Eschwege E, Richard JL, Thibult N, et al. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, 10 years later. Horm Metab Res Suppl. 1985;15:41-46.
42. Butler WJ, Ostrander LD, Carman WJ, et al. Mortality from coronary heart disease in the Tecumseh study. Long-term effect of diabetes mellitus, glucose tolerance and other risk factors. Am J Epidemiol. 1985;121:541-547.
43. Pan WH, Cedres LB, Liu K, et al. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol. 1986;123:504-516.
44. Vane JR, Anggard EE, Botting RM. Mechanisms of disease: regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27-36.
45. Idris I, Gray S, Donnelly R. Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications on diabetes. Diabetologia. 2001;44:659-673.
46. Park L-Y, Takahara N, Gabriele A, et al. Induction of endothelin-1 expression by glucose. An effect of protein kinase C activation. Diabetes. 2000;49:1239-1248.
47. Ting HH, Timimi FK, Boles KS, et al. Vitamin C improves endothelium-dependent vasodilatation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1996;97:22-28.
48. Singh R, Barden A, Mori T, et al. Advanced glycation end products: a review. Diabetologia. 2001;44:129-146.
49. Frustaci A, Kajstura J, Chimenti C, et al. Myocardial cell death in human diabetes. Circ Res. 2000;87:1123-1132.
50. Wells L, Vosseller K, Hart GW. Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science. 2001;291:2376-2378.
51. Dillman W. Diabetes mellitus induces changes in cardiac myosin of the rat. Diabetes. 1980;29:579-582.
52. Factor SM, Bhan R, Minase T, et al. Hypertensive-diabetic cardiomyopathy in the rat: an experimental model of human disease. Am J Pathol. 1981;102:219-228.
53. Zhou Y, Grayburn P, Karim A, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A. 2000;97:1794-1789.